Cofoe Medical released its 2026 interim report. During the reporting period, the company achieved total operating revenue of 2.072 billion yuan and net profit attributable to the parent company of 202 million yuan. Net cash inflow from operating activities was 262 million yuan, a decrease of 89.0221 million yuan compared with the same period last year, down 25.33 percent year on year. The company's latest asset-liability ratio was 25.41 percent, an increase of 0.62 percentage points from the same period last year. Gross margin was 55.89 percent, return on equity was 3.66 percent, and diluted earnings per share was 0.95 yuan. The number of shareholders was 15,200, and the top ten shareholders held a combined 159 million shares, accounting for 67.46 percent of the total share capital.
Cofoe Medical Technology Co.Ltd.Company reports net profit of 202 million yuan and revenue of 2.072 billion yuan in interim report.